466
Participants
Start Date
January 4, 2024
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2027
INCB161734
INCB161734 will be administered at protocol defined dose.
Cetuximab
Cetuximab will be administered at protocol defined dose.
Retifanlimab
Retifanlimab will be administered at protocol defined dose.
GEMNabP
GEMNabP will be administered at protocol defined dose.
mFOLFIRINOX
mFOLFIRINOX will be administered at protocol defined dose.
RECRUITING
Peter Maccallum Cancer Centre, North Melbourne
RECRUITING
Weill Cornell Medicine, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Irccs Istituto Clinico Humanitas, Rozzano
RECRUITING
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan
RECRUITING
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
RECRUITING
Fundacion Jimenez Diaz, Madrid
RECRUITING
Hospital Universitario Quironsalud Madrid, Madrid
RECRUITING
Universitaire Du Cancer de Toulouse Institut Claudius Regaud Iuct-Oncopole, Toulouse
RECRUITING
Centro Ricerche Cliniche Di Verona, Verona
RECRUITING
Scri Oncology Partners, Nashville
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Md Anderson Cancer Center, Houston
RECRUITING
Sarah Cannon Research Institue At Healthone, Denver
RECRUITING
Mayo Clinic Hospital, Phoenix
RECRUITING
UCLA Healthcare Hematology-Oncology, Santa Monica
RECRUITING
Stanford University, Palo Alto
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Hackensack University Medical Center, Hackensack
RECRUITING
Chris Obrien Lifehouse, Camperdown
RECRUITING
St Vincent'S Hospital Sydney, Darlinghurst
RECRUITING
The Alfred Hospital, Melbourne
RECRUITING
Linear Clinical Research, Nedlands
RECRUITING
Cliniques Universitaires Ucl Saint-Luc, Brussels
RECRUITING
Universitair Ziekenhuis Antwerpen (Uza), Edegem
RECRUITING
Universitair Ziekenhuis (Uz) Leuven, Leuven
RECRUITING
The Ottawa Hospital Cancer Center, Ottawa
RECRUITING
Princess Margaret Cancer Center, Toronto
RECRUITING
National Cancer Center Hospital East, Chiba
RECRUITING
The Cancer Institute Hospital of Jfcr, Kōtoku
RECRUITING
Hospital General Universitario Vall D Hebron, Barcelona
Lead Sponsor
Incyte Corporation
INDUSTRY